Atlas Trials

A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

Clinical trial NCT02585700 · COMPLETED

Trial details

NCT number
NCT02585700
Sponsor
Institute of Virology, Vaccines and Sera, Torlak
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Influenza, Human
Start date
2015-11-01
Primary completion
2016-03-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.